Prescribing of phosphodiesterase-5 inhibitors among psychiatrists

Journal of Sex and Marital Therapy

Volumn 40, Issue 3, 2014, Pages 165-169

  Balon, Richard ^a   Morreale, Mary K ^a   Segraves, R Taylor ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; PSYCHOTROPIC AGENT;

ADULT; AGED; CHEMICALLY INDUCED DISORDER; CLINICAL PRACTICE; DRUG UTILIZATION; ERECTILE DYSFUNCTION; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; INFORMATION PROCESSING; LETTER; MALE; MIDDLE AGED; OFF LABEL DRUG USE; PSYCHIATRY; SEXUAL DYSFUNCTION; STATISTICS; UNITED STATES;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; DATA COLLECTION; DRUG UTILIZATION; ERECTILE DYSFUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; OFF-LABEL USE; PHOSPHODIESTERASE 5 INHIBITORS; PHYSICIAN'S PRACTICE PATTERNS; PSYCHIATRY; PSYCHOTROPIC DRUGS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; UNITED STATES;

EID: 84897597654     PISSN: 0092623X     EISSN: 15210715     Source Type: Journal    
DOI: 10.1080/0092623X.2013.788111     Document Type: Letter

References (11)

1. Arfken, C.L., &, Balon, R. (2011). Declining participation in research studies. Psychotherapy and Psychosomatics, 80, 325-328.
2. Asimakoulos, A.D., Miano, R., Finazzi Agro, E., Vespasiani, G., &, Spera, E. (2012). Does current scientific and clinical evidence support the use of phoshodiesterase type 5 inhibitors for the treatment of premature ejaculation? A systematic review and meta-analysis. Journal of Sexual Medicine, 9, 2004-2016.
3. Balon, R. (2006). SSRI-associated sexual dysfunction. American Journal of Psychiatry, 163, 1504-1509. (Pubitemid 44465749)
4. Balon, R., Mufti, R., &, Arfken, C.L. (1999). A survey of prescribing practices for monoamine oxidase inhibitors. Psychiatric Services, 50, 945-947. (Pubitemid 29309869)
5. Fava, M., Hurnberg, H.G., Seidman, S.N., Holloway, W., Nicholas, S., Tseng, L.-J., &, Stecher, V.J. (2006). Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: Results from a randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychiatry, 67, 240-246. (Pubitemid 43357470)
6. Jannini, E.A., McMahon, C., Chen, J., Aversa, A., &, Perelman, M. (2011). The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation. Journal of Sexual Medicine, 8, 2135-2143.
7. Nurnberg, H.G., Fava, M., Gelenberg, A.J., Hensley, P.L., &, Paine, S. (2007). Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction. International Journal of Impotence Research, 19, 167-175. (Pubitemid 46340834)
8. Nurnber, H.G., Hensley, P.L., Heiman, J., Croft, H., Debattista, C., &, Paine, S. (2008). Sildenafil treatment of women with antidepressant0associated sexual dysfunction. A randomized controlled trial. JAMA, 300, 395-404. (Pubitemid 352040251)
9. Schoen, C., &, Bachmann, G. (2009). Sildenafil citrate for female sexual arousal disorder: A future possibility? Nature Reviews Urology, 6, 216-222.
10. Segraves, R., &, Balon, R. (2003). Sexual pharmacology. Fast facts. New York, NY: Norton.
11. Segraves, R., Lee, J., Stevenson, R., Walker, D.J., Wang, W.C., &, Dickson, R.A. (2007). Tadalafil for treatment of erectile dysfunction in men on antidepressants. Journal of Clinical Psychopharmacology, 27, 62-66. (Pubitemid 46105767)